An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate

Stopped Due to small number of participants entering randomization. Not a safety issue.

Conditions

• Rheumatoid Arthritis

Interventions

• DRUG: Sarilumab
• DRUG: Etanercept
• DRUG: Methotrexate
• DRUG: Placebo (for sarilumab)
• DRUG: Placebo (for etanercept)
• DRUG: Adalimumab

Sponsor

Sanofi

Collaborators

• [object Object]